I'm not going to claim to be an expert on the healthcare sector, but I am confident that my investment in Medtronic is going to set me up for life, or at least for a lifetime of reliable income.

Medtronic noted that the system's "treat to target" approach and the option to set glucose targets as low as 100mg/dL enable it to mimic non-diabetic glucose levels closely. Its real-world data ...